QuadraMed

Name: QuadraMed
Brand: QuadraMed

The only vendor that can Diagnose, Treat, Cure & Prevent dangerous patient identity issues.

Est 1993|19 Ref Customers

LinkedIn 3K|Website|FTEs 263|HQ Plano, Texas, US

MarketsMaster Data Management (MDM)

Published Sep 17, 2026

01Common complaints

- Company sizes or stages where this product is overkill or insufficient - Very small clinics and hospitals with limited system fragmentation may not justify a dedicated EMPI platform and associated services. - Industries or use cases where competitors are more suitable - If selection criteria prioritize publicly documented security certifications (for example, explicit HITRUST statements on vendor websites), competitors that publish these details may be easier to evaluate during procurement. (https://verato.com/platform/why-verato/security/?utm_source=openai) - Technical requirements that this product cannot be confirmed to meet from public information - Public documentation did not clearly confirm cloud-native deployment options, supported identity APIs/event streams, or real-time matching SLAs. If these requirements are non-negotiable, buyers should obtain direct vendor confirmation and perform a technical evaluation. - Budget constraints that make alternatives more appropriate - Organizations that cannot fund ongoing stewardship and professional services may prefer smaller-scope data quality approaches or embedded EHR tooling. - Specific workflows or integrations where additional validation is recommended - Community feedback includes complaints about scanned document navigation in at least one QuadraMed deployment; if clinician document review UX is a priority, validate behavior during product demonstrations with the target configuration. (https://www.reddit.com/r/healthIT/comments/qau22u?utm_source=openai) - Procurement diligence considerations - Limited public information on pricing, certifications, and detailed product documentation increases the diligence burden on the buyer (RFPs, security reviews, and reference calls are likely required). - Current limitations acknowledged by the vendor - No explicit public document labeled "known issues/limitations" was located during this research. - Features on the roadmap (not yet available) - Roadmap details were not found in the sources reviewed. - Scale limitations (at what volume/size does it break down?) - No public specification of scale limitations was found. - Security or compliance gaps - Public evidence for modern certifications (SOC 2, ISO 27001, HITRUST) was not found in this research. - Technical debt or architectural limitations mentioned in reviews - Community feedback suggests some deployments may have user experience issues in specific workflows (for example, scanned document navigation). - API limitations or integration constraints - Public technical documentation detailing APIs and connectors was not located in the accessible sources reviewed.

02Why they buy

- Competitive advantages indicated by available evidence (not only vendor claims) - Historical market presence and references suggest QuadraMed has been used in EMPI and HIE contexts for a number of years; continued operation under Harris indicates ongoing availability of these offerings. (https://www.harrishealthcare.com/news/press-release/constellation-acquires-quadramed-corporation/?utm_source=openai) - Unique features and capabilities (publicly verifiable) - Public sources did not reveal clearly unique technical features that are independently verifiable in this research. Buyers should request feature matrices, integration lists, and third-party validation. - Differentiation from competitors based on available materials - QuadraMed appears to follow a combined software-and-services model via Harris Data Integrity Solutions; competitors may emphasize cloud-native architectures or referential matching approaches. - Areas where competitors have clearer public advantages - Competitors such as Verato publish more explicit security/compliance messaging and case-study outcomes, which can simplify initial procurement assessments. (https://verato.com/platform/why-verato/security/?utm_source=openai)

03Field reports

- Review-platform availability reality check - Gartner Peer Insights and other review platforms are available, but product-specific QuadraMed reviews were not readily retrievable in this research session (platform access restrictions, limited coverage, or discoverability constraints may apply). (Official review platform pages) - TrustRadius and Capterra searches did not surface an obvious QuadraMed product review page within the accessible results during this run. (Vendor review and comparison sites) - Community/social commentary (Reddit) — direct quotes - Positive/neutral sentiment (UK doctors discussing EPR systems): - “LTH (Preston) had this system called Quadramed, which I think has been overhauled but was decent.” (Reddit community thread) - Mixed usability complaint (document viewing workflow): - “I used Quadramed at my previous job… I find it greatly annoying… not to allow continuous scroll of scanned documents… having to manually click on 20 different 2-3 page forms is irritating.” (Reddit community thread) - Strong negative sentiment in a pharmacy software tier list (appears to refer to QuadraMed in a pharmacy context): - “Meditech Magic, Quadramed - F” (Reddit community thread) - Vendor/curated testimonial sources (use cautiously) - Vendor directory listings and marketing-hosted case studies list QuadraMed references and customer use cases; these sources are vendor-adjacent and should be verified independently where possible. - Why customers chose this product over alternatives (evidence signals) - Older coverage emphasizes probabilistic matching, reconciliation across sources, and assigning enterprise identifiers—common reasons organizations select dedicated EMPI products rather than relying solely on local MRNs. These points are primarily based on vendor and partner statements and should be validated during reference calls. - Why some customers left for competitors (churn reasons) - No direct QuadraMed-to-competitor churn narratives were found in the accessible sources reviewed. Industry churn drivers in the EMPI category include large backlogs, false positives/negatives, and inability to support digital front door initiatives; these are general category observations rather than QuadraMed-specific findings. (Industry analysis and vendor/partner resources)

DFWHC Foundation case study (regional EMPI / large-scale records)

- A case study describes using QuadraMed EMPI to help a Texas foundation manage and link large volumes of patient records. The document is vendor/partner-published and should be interpreted as such. - Critical gaps: - Limited methodological transparency (definitions for baseline error rates, time period, and independent audit information were not provided). - Outcomes may depend on local governance and stewardship processes in addition to software capabilities. - Source documents: - Vendor/partner-published case study PDF (DFWHC Foundation) - Vendor/partner presentation material supporting the case study

"Large Integrated Healthcare System" EMPI case study (hosted)

A hosted case study describes EMPI deployment and EHR historical record loading. The customer name may be anonymized; results and scope are difficult to validate independently.
Source: Third-party hosted customer case study PDF

Government/standards context mention

The U.S. HealthIT.gov “Master Data Management within HIE” guidance references QuadraMed’s SmartIX as an EMPI solution, indicating QuadraMed was part of HIE/MDM discussions in that period. This reference is contextual and not an endorsement of product performance.
Source: U.S. HealthIT.gov master data management guidance document

04Best fit

- Company sizes - Best fit typically skews toward: - Mid-to-large health systems and multi-facility networks - Regional/community health information exchanges - Organizations managing very large identity volumes where duplicate prevention and stewardship automation materially impact cost and safety - Industries and verticals where adoption is strongest - Hospitals and health systems - HIEs / interoperability networks - Analytics, population health, and research organizations managing community datasets (as described in DFWHC materials) - Roles and personas: decision makers AND end users - Decision makers: CIO/CTO, VP of Data/Interoperability, HIM leadership, Revenue cycle leadership - End users: HIM data stewards / MPI teams, registration/patient access staff, integration engineers - Pain points and challenges the product addresses - Duplicate medical records and overlays - Fragmented identities across EHR and ancillary systems - Operational burden associated with manual identity stewardship queues - Qualification criteria: what makes a GOOD fit - Clear governance for identity resolution and stewardship - Willingness to invest in data quality processes in addition to software - Multi-source identity complexity (e.g., mergers, multiple EHRs, HIE feeds) - Deal disqualifiers: what makes a POOR fit - Very small single-facility organizations with minimal duplicates and low integration complexity - Organizations expecting a purely plug-and-play matching solution without operational stewardship - Buyers requiring publicly posted security attestations (SOC2/ISO/HITRUST) as a procurement prerequisite unless the vendor can provide these under NDA - Real customer examples with company names when available - The DFWHC Foundation case study references a regional/community-scale use case - Additional named customer logos may exist in marketing directories; independent verification was not performed for this research.

05The pitch

What the product does (core value proposition in objective terms)

- QuadraMed is described as a healthcare identity and data integrity vendor focused on Enterprise Master Patient Index (EMPI) capabilities, patient matching, and duplicate record prevention/clean-up services. The stated objective is to reduce patient safety risk and administrative/billing errors caused by fragmented identities. - The vendor’s public-facing site currently appears to function primarily as a brand entry point for Harris Data Integrity Solutions (the business unit combining QuadraMed and related identity/data offerings) rather than a fully detailed, standalone product site. (Official vendor brand and product pages)

Target market and market positioning

Primary buyers appear to be health systems, hospitals, health information exchanges (HIEs), and health-data organizations that require identity resolution at enterprise or community scale.
Positioning emphasizes EMPI capabilities (identity accuracy, interoperability enablement, preventing duplicate records at registration/points of entry). (Company LinkedIn and vendor positioning materials)

Get a comprehensive analysis of QuadraMed including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →